Defining a Central Monitoring Capability: Sharing the Experience of TransCelerate BioPharmas Approach, Part 2

Conclusions:
One of the primary issue detection methods of central monitoring is the proactive identification of areas of focus through the use of risk indicators.

Source: Therapeutic Innovation and Regulatory Science - December 30, 2015 Category: Drugs & Pharmacology Authors: Gough, J., Wilson, B., Zerola, M., Wallis, P., Mork, L., Knepper, D., Achenbach, H. Tags: Sponsored Special Section by TransCelerate BioPharma Source Type: research